(Q37948164)

English

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.

scientific article published on 21 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Helicobacter pylori

0 references

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

Javier P Gisbert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

0 references

publication date

21 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

34

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

11-12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1255-1268

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22017749%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Clinical practice. Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

"Cervia II Working Group Report 2006": guidelines on diagnosis and treatment of Helicobacter pylori infection in Italy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Antibiotic resistance in Helicobacter pylori: implications for therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

H pylori antibiotic resistance: prevalence, importance, and advances in testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Esomeprazole-based Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Seven-day therapy for Helicobacter pylori in the United States

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Treatment of Helicobacter pylori infection 2010.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

New concepts of resistance in the treatment of Helicobacter pylori infections

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Esomeprazole-based therapy in Helicobacter pylori eradication: any effect by increasing the dose of esomeprazole or prolonging the treatment?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

A 9 year study of clarithromycin and metronidazole resistance in Helicobacter pylori from Spanish children

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

The status of antimicrobial resistance of Helicobacter pylori in eastern Europe.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Prevalence of antibiotic resistance of Helicobacter pylori isolates in Estonia during 1995-2000 in comparison to the consumption of antibiotics used in treatment regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998–2002

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Alarming clarithromycin resistance of Helicobacter pylori in Turkish population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Should anti-Helicobacter therapy be different in patients with dyspepsia compared with patients with peptic ulcer diathesis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

How can the current strategies for Helicobacter pylori eradication therapy be improved?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2011.04887.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37948164&oldid=2106096491"